Arch Plast Surg.  2020 Sep;47(5):478-482. 10.5999/aps.2020.00108.

Breast implant-associated anaplastic large cell lymphoma in an Asian patient: The first case report from Thailand

Affiliations
  • 1PSC Clinic, Nonthaburi, Thailand
  • 2Division of Dermatology, Department of Medicine, Thammasat University, Pathumthani, Thailand
  • 3Department of Pathology and Forensic Medicine, Thammasat University, Pathumthani, Thailand

Abstract

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has received increasing interest among plastic surgeons as a long-term complication of breast augmentation. Although the prognosis is usually good, mortality is a possible outcome. Most of the cases reported in the past two decades have been from the United States, Europe, and Australia, whereas cases of BIA-ALCL in Asia remain rare. Herein, we describe the first known case of BIA-ALCL in Thailand, in which a 32-year-old woman developed BIA-ALCL 3 years after breast augmentation using textured implants. The patient underwent bilateral removal of the implants and ipsilateral total capsulectomy. This case report—the first of its kind from Thailand—should increase awareness of BIA-ALCL among plastic surgeons in Asia. The true incidence of BIA-ALCL in Asia may be underreported.

Keyword

Breast implant-associated anaplastic large cell lymphoma; Lymphoma, large-cell, anaplastic; Lymphoma, non-Hodgkin; CD30
Full Text Links
  • APS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr